Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
bioAffinity Technologies, Inc. - Common Stock
(NQ:
BIAF
)
0.8150
+0.0150 (+1.87%)
Streaming Delayed Price
Updated: 2:32 PM EDT, Jun 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about bioAffinity Technologies, Inc. - Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
What's going on in today's after hours session
↗
March 31, 2025
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
12 Health Care Stocks Moving In Monday's After-Market Session
↗
March 31, 2025
Via
Benzinga
bioAffinity Technologies Reports Record $9.4 Million Revenue for 2024
March 31, 2025
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
March 28, 2025
Via
ACCESS Newswire
Case Study: bioAffinity Technologies’ CyPath® Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer
March 26, 2025
From
bioAffinity Technologies, Inc.
Via
Business Wire
Case Study: bioAffinity Technologies’ Positive CyPath® Lung Result Leads to Detecting Breast Cancer Recurrence
March 19, 2025
From
bioAffinity Technologies, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
March 18, 2025
Via
Benzinga
Monday's session: top gainers and losers
↗
March 17, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session.
↗
March 17, 2025
Intrigued by the market activity in the middle of the day on Monday? Uncover the key winners and losers of today's session in our insightful analysis.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
March 17, 2025
Via
Benzinga
Traders are paying attention to the gapping stocks in Monday's session.
↗
March 17, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.
Via
Chartmill
Physicians’ Case Studies Offer Insight into Use and Benefit of CyPath® Lung in Avoiding Unnecessary Invasive Procedures and Detecting Lung Cancer
March 13, 2025
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Announces Targeted Actions to Cut $4 Million in Costs and Drive CyPath® Lung Sales Growth
March 06, 2025
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Announces Closing of Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million
February 26, 2025
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Announces Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million
February 25, 2025
From
bioAffinity Technologies, Inc.
Via
Business Wire
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029
January 30, 2025
EQNX::TICKER_START (NASDAQ:INBS),(NASDAQ:CDIO),(NASDAQ:BIAF),(NASDAQ:TRIB),(NASDAQ:SOBR) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Cannabis
Death
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029
January 30, 2025
From
FN Media Group LLC
Via
GlobeNewswire
bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic
January 22, 2025
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports Positive Results from Texas Beta Launch of CyPath® Lung
January 13, 2025
From
bioAffinity Technologies, Inc.
Via
Business Wire
Enlivex Therapeutics and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
January 10, 2025
Via
ACCESSWIRE
Join bioAffinity Technologies’ Exclusive Live Investor Webinar and Q&A Session on Thursday, December 19
December 17, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Set for Continued Expansion in 2025
December 12, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Veterans’ Research Foundation Spotlights CyPath® Lung’s Addition to the Federal Supply Schedule
December 05, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024
November 14, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development
November 04, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
November 01, 2024
Via
Benzinga
bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung
October 30, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
October 23, 2024
Via
Benzinga
bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement
October 21, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
October 18, 2024
Via
Benzinga
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
